| ST002255 Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics with ATP) | ||||
| Limit by pathway class: | ||||
| ST002255 Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics with ATP) | ||||
| Limit by pathway class: | ||||
|